Hazlett Burt & Watson Inc. Lowers Stake in Procter & Gamble Company (The) $PG

Hazlett Burt & Watson Inc. lowered its position in shares of Procter & Gamble Company (The) (NYSE:PG) by 1.6% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 16,083 shares of the company’s stock after selling 259 shares during the quarter. Procter & Gamble accounts for about 1.0% of Hazlett Burt & Watson Inc.’s investment portfolio, making the stock its 19th largest position. Hazlett Burt & Watson Inc.’s holdings in Procter & Gamble were worth $2,562,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the company. Almanack Investment Partners LLC. lifted its holdings in Procter & Gamble by 12.1% during the second quarter. Almanack Investment Partners LLC. now owns 7,809 shares of the company’s stock valued at $1,244,000 after purchasing an additional 845 shares in the last quarter. Yarger Wealth Strategies LLC lifted its holdings in Procter & Gamble by 13.8% during the second quarter. Yarger Wealth Strategies LLC now owns 2,565 shares of the company’s stock valued at $409,000 after purchasing an additional 311 shares in the last quarter. Retirement Planning Group LLC NY lifted its holdings in Procter & Gamble by 2.8% during the second quarter. Retirement Planning Group LLC NY now owns 2,775 shares of the company’s stock valued at $442,000 after purchasing an additional 76 shares in the last quarter. GW Henssler & Associates Ltd. lifted its holdings in Procter & Gamble by 2.3% during the second quarter. GW Henssler & Associates Ltd. now owns 4,074 shares of the company’s stock valued at $649,000 after purchasing an additional 92 shares in the last quarter. Finally, Alpha Financial Partners LLC lifted its holdings in Procter & Gamble by 19.4% during the second quarter. Alpha Financial Partners LLC now owns 1,504 shares of the company’s stock valued at $240,000 after purchasing an additional 244 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

Procter & Gamble stock opened at $149.69 on Monday. The company’s 50-day moving average price is $155.24 and its 200-day moving average price is $159.41. Procter & Gamble Company has a twelve month low of $149.45 and a twelve month high of $180.43. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. The company has a market cap of $350.34 billion, a PE ratio of 22.99, a price-to-earnings-growth ratio of 3.97 and a beta of 0.36.

Procter & Gamble (NYSE:PG) last posted its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. During the same period in the previous year, the firm posted $1.40 EPS. The business’s quarterly revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities research analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Insider Transactions at Procter & Gamble

In other news, insider Balaji Purushothaman sold 490 shares of the business’s stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $74,592.70. Following the sale, the insider directly owned 12,616 shares in the company, valued at $1,920,533.68. The trade was a 3.74% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Shailesh Jejurikar sold 3,986 shares of the business’s stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $606,788.78. Following the transaction, the chief operating officer owned 46,899 shares in the company, valued at $7,139,434.77. This trade represents a 7.83% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

PG has been the topic of several analyst reports. Barclays lowered their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 1st. Evercore ISI reissued an “in-line” rating and issued a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. UBS Group lowered their target price on shares of Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a report on Wednesday. BNP Paribas Exane lowered their target price on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a report on Tuesday, September 23rd. Finally, BNP Paribas reissued an “outperform” rating and issued a $177.00 target price on shares of Procter & Gamble in a report on Friday, August 15th. Eleven analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Procter & Gamble has a consensus rating of “Moderate Buy” and a consensus price target of $172.21.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.